摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

9-Deoxo-FK 506 | 133951-08-3

中文名称
——
中文别名
——
英文名称
9-Deoxo-FK 506
英文别名
9-deoxo-FK506;9-deoxoFK506;(1S,9S,12S,13R,14S,17R,18E,21S,23S,24R,25S,27R)-1,14-dihydroxy-12-[(E)-1-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]prop-1-en-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-17-prop-2-enyl-11,28-dioxa-4-azatricyclo[22.3.1.04,9]octacos-18-ene-3,10,16-trione
9-Deoxo-FK 506化学式
CAS
133951-08-3
化学式
C44H71NO11
mdl
——
分子量
790.048
InChiKey
FRSCEVMAMNXXSW-WTDYSYIZSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    872.6±65.0 °C(Predicted)
  • 密度:
    1.16±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.8
  • 重原子数:
    56
  • 可旋转键数:
    7
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.8
  • 拓扑面积:
    161
  • 氢给体数:
    3
  • 氢受体数:
    11

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    9-Deoxo-FK 506还原型辅酶II(NADPH)四钠盐 作用下, 以 aq. phosphate buffer 为溶剂, 反应 3.0h, 生成 9-hydroxyFK506 、 他克莫司
    参考文献:
    名称:
    Characterization of FK506 Biosynthetic Intermediates Involved in Post-PKS Elaboration
    摘要:
    The post-PKS modification steps of FK506 biosynthesis include C9-oxidation. and 31-O-methylation, but the sequence of these reactions and the exact route have remained unclear. This Study details the post-PM modification pathways in FK506 biosynthesis through the identification of all intermediates and in vitro enzymatic reactions of the cytochrome P450 hydroxylase FkbD and the methyltransferase FkbM. These results complete our understanding of post-PKS, Modification steps to FK506 showing the substrate flexibility of two enzymes involved and the existence of two parallel biosynthetic routes to FK506.
    DOI:
    10.1021/np4001224
  • 作为产物:
    描述:
    他克莫司吡啶硫化氢 作用下, 以 甲醇 为溶剂, 生成 9-Deoxo-FK 506
    参考文献:
    名称:
    从与雷帕霉素和FK506由反应有效地除去2-哌啶的Ñ -Bu 4 Ñ + CN -
    摘要:
    雷帕霉素(反应1)和FK506(11)配有Ñ -Bu 4 Ñ + CN - /水溶液。THF导致其哌考林酯亚基的有效切除,分别导致化合物3和12的良好收率。发生两个连续的环裂解反应:三羰基官能团的快速氰化物促进的断裂,然后是较慢的氰化物催化的酯裂解。氰化物试剂为结构复杂的底物中的分子内酯交换反应提供了温和的化学选择性系统。
    DOI:
    10.1016/s0040-4039(00)60634-2
点击查看最新优质反应信息

文献信息

  • Synthesis of derivatives of FK 506 and FR 900520: modifications at the binding domain
    作者:Gerhard Emmer、Sabine Weber-Roth
    DOI:10.1016/s0040-4020(01)90178-4
    日期:1992.7
    The synthesis of 9-deoxo-FK 506 (13a), 9-deoxo-FR 900520 (13b), 9-deoxo-10(R)-deoxy-FR 900520 (14) and its 10(S) isomer 15 is described. Radical deoxygenation/elemination of the 9-di-hydro-9,10-thiocarbonates 5a,5b,6a and 6b gave the 9,10 unsaturated compounds 7a (7b) or 8a (8b) which were further transferred by hydration or hydrogenation. Different E/Z ratios of 7a (7b) were obtainted when nBu3SnH or [(CH3)3Si]3SiH in combination with AIBN or Et3B were used, allowing the selective preparation of both isomers. Two possible reaction mechanisms are discussed.
  • Efficient removal of pipecolinate from rapamycin and FK506 by reaction with n-Bu4N+CN−
    作者:Juan I. Luengo、Leonard W. Rozamus、Dennis A. Holt
    DOI:10.1016/s0040-4039(00)60634-2
    日期:1993.9
    pipecolinate subunits, leading in good yields to compounds 3 and 12, respectively. Two sequential ring cleavage reactions take place: a fast cyanide-promoted fragmentation of the tricarbonyl functionality followed by a slower cyanide-catalyzed ester cleavage. The cyanide reagent provides a mild, chemoselective system for intramolecular transesterifications in structurally complex substrates.
    雷帕霉素(反应1)和FK506(11)配有Ñ -Bu 4 Ñ + CN - /水溶液。THF导致其哌考林酯亚基的有效切除,分别导致化合物3和12的良好收率。发生两个连续的环裂解反应:三羰基官能团的快速氰化物促进的断裂,然后是较慢的氰化物催化的酯裂解。氰化物试剂为结构复杂的底物中的分子内酯交换反应提供了温和的化学选择性系统。
  • Characterization of FK506 Biosynthetic Intermediates Involved in Post-PKS Elaboration
    作者:Yeon Hee Ban、Pramod B. Shinde、Jae-yeon Hwang、Myoung-Chong Song、Dong Hwan Kim、Si-Kyu Lim、Jae Kyung Sohng、Yeo Joon Yoon
    DOI:10.1021/np4001224
    日期:2013.6.28
    The post-PKS modification steps of FK506 biosynthesis include C9-oxidation. and 31-O-methylation, but the sequence of these reactions and the exact route have remained unclear. This Study details the post-PM modification pathways in FK506 biosynthesis through the identification of all intermediates and in vitro enzymatic reactions of the cytochrome P450 hydroxylase FkbD and the methyltransferase FkbM. These results complete our understanding of post-PKS, Modification steps to FK506 showing the substrate flexibility of two enzymes involved and the existence of two parallel biosynthetic routes to FK506.
查看更多

同类化合物

马杜霉素II 雷帕霉素 长川霉素 达福普丁甲磺酸 西罗莫司脂化物 蛎灰菌素A 子囊霉素 威里霉素 唑他莫司 吡美莫司 双氢他克莫司 去甲氧基雷帕霉素 化合物 T32504 化合物 T25424 依维莫司 他克莫司杂质5 他克莫司31-DMT 他克莫司 乌米里莫斯 FK-506一水合物 8-表他克莫司 8,9,14,15,24,25,26,26alpha-八氢-14-羟基-4,12-二甲基-3-(1-甲基乙基)-(3R,4R,5E,10E,12E,14S,26alphaR)-3H-21,18-次氮基-1H,22H-吡咯并[2,1-c][1,8,4,19]二氧杂二氮杂二十四环-1,7,16,22(4H,17H)-四酮 42-O-[2-[[羟基[2-(三甲基铵)乙氧基]亚膦酰基]氧基]乙基]雷帕霉素内盐 42-(二甲基亚膦酰)雷帕霉素 42-(2-四唑基)雷帕霉素 40-O-[2-(叔丁基二甲硅基)氧代]乙基雷帕霉素 37-去亚甲基24,33-二-O-(叔-丁基二甲基硅烷基)-37-氧代-FK-506 31-O-去甲基-Fk506 28-O-甲基-雷帕霉素 24,33-二-O-(叔-丁基二甲基硅烷基)-37,38-去氢-37,38-二羟基-FK-506 24,32-双-O-(tert-butyldimethylsilyl)-他克莫司 22-羟基-33-叔-丁基二甲基硅烷基氧基-异-FK-506 2-甲氧基-5-硝基嘧啶-4-胺 19-表FK-506 15-O-去甲基长川霉素 13-O-去甲基子囊霉素 (E/Z)-FK-50626,28-烯丙酸酯 (2S,5S,6R,10R,11S)-10-庚基-6-羟基-4,11-二甲基-5-(苯基甲基)-2-丙-2-基-1,9-二氧杂-4-氮杂环十二烷-3,8,12-三酮 (1R,2R,4S)-4-{(2R)-2-[(1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-二羟基-19,30-二甲氧基-15,17,21,23,29,35-六甲基-2,3,10,14,20-五氧代-11,36-二氧杂-4-氮杂三环[30.3.1.04,9]三十六碳-16,24,26,28-四烯-12-基]丙基}-2-甲氧基环己基2,2,5-三甲基-1,3-二恶烷-5-羧酸酯 (21S)-1-aza-4,4-dimethyl-6,19-dioxa-2,3,7,20-tetraoxobicyclo<19.4.0>pentacosane CCI-779 boronate rapamycin (-)-spongedepsin (1R,9S,12SR,15R,16E,18R,19R,21R,23S,24E,26E,28E,32SR,35R)-1,18-dihydroxy-30-(3-hydroxypropoxy)-19-methoxy-12-[(1R)-2-[(1S,3R,4R)-3-methoxy-4-(3-phenylpropoxy)cyclohexyl]-1-methylethyl]-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo[30.3.1.0^4,9]hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentone rapamycin 42-hemiadipate Rapamycin 42-ester with 4-methylpiperazine-1-carboxylic acid rapamycin O-[(S)-2,3-dihydroxypropyloxycarbonyl]rapamycin 29-epirapamycin 40-O-tert-butyldimethylsilyl rapamycin